Cargando…

Cost-Effectiveness of Pharmacotherapy to Reduce Obesity

AIMS: Obesity causes a high disease burden in Australia and across the world. We aimed to analyse the cost-effectiveness of weight reduction with pharmacotherapy in Australia, and to assess its potential to reduce the disease burden due to excess body weight. METHODS: We constructed a multi-state li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veerman, J. Lennert, Barendregt, Jan J., Forster, Megan, Vos, Theo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203105/ https://www.ncbi.nlm.nih.gov/pubmed/22046255 http://dx.doi.org/10.1371/journal.pone.0026051

Ejemplares similares

The Cost-Effectiveness of Laparoscopic Adjustable Gastric Banding in the Morbidly Obese Adult Population of Australia
por: Lee, Yong Yi, et al.
Publicado: (2013)

The national burden of road traffic injuries in Thailand
por: Ditsuwan, Vallop, et al.
Publicado: (2011)

Cost-Effectiveness of Interventions to Promote Fruit and Vegetable Consumption
por: Cobiac, Linda J., et al.
Publicado: (2010)

By how much would limiting TV food advertising reduce childhood obesity?
por: Veerman, J. Lennert, et al.
Publicado: (2009)

Cost-Effectiveness of Interventions to Promote Physical Activity: A Modelling Study
por: Cobiac, Linda J., et al.
Publicado: (2009)

Cost-Effectiveness of Preventive Interventions to Reduce Alcohol Consumption in Denmark
por: Holm, Astrid Ledgaard, et al.
Publicado: (2014)

Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study
por: Cobiac, Linda J, et al.
Publicado: (2012)

Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents
por: Lim, Francesca, et al.
Publicado: (2023)

The cost‐effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity
por: Lee, Minyi, et al.
Publicado: (2019)

The health and economic impact and cost effectiveness of interventions for the prevention and control of overweight and obesity in Kenya: a stakeholder engaged modelling study
por: Wanjau, Mary Njeri, et al.
Publicado: (2023)

Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study
por: Marklund, Matti, et al.
Publicado: (2020)

Priority-setting for obesity prevention—The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study
por: Ananthapavan, Jaithri, et al.
Publicado: (2020)

Taxes and Subsidies for Improving Diet and Population Health in Australia: A Cost-Effectiveness Modelling Study
por: Cobiac, Linda J., et al.
Publicado: (2017)

The productivity gains associated with a junk food tax and their impact on cost-effectiveness
por: Carter, Hannah E., et al.
Publicado: (2019)

Contribution of Trans-Fatty Acid Intake to Coronary Heart Disease Burden in Australia: A Modelling Study
por: Wu, Jason H. Y., et al.
Publicado: (2017)

Evidence that a tax on sugar sweetened beverages reduces the obesity rate: a meta-analysis
por: Cabrera Escobar, Maria A, et al.
Publicado: (2013)

Pharmacotherapy for Obesity
por: Joo, Jong Kil, et al.
Publicado: (2014)

Cost-effectiveness analysis of population salt reduction interventions to prevent cardiovascular disease in Cameroon: mathematical modelling study
por: Aminde, Leopold Ndemnge, et al.
Publicado: (2020)

Cost-effectiveness of changes in alcohol taxation in Denmark: a modelling study
por: Holm, Astrid Ledgaard, et al.
Publicado: (2014)

The Impact of a Tax on Sugar-Sweetened Beverages on Health and Health Care Costs: A Modelling Study
por: Veerman, J. Lennert, et al.
Publicado: (2016)

The avoidable disease burden associated with overweight and obesity in Kenya: A modelling study
por: Wanjau, Mary Njeri, et al.
Publicado: (2022)

Estimated health benefits, costs and cost-effectiveness of eliminating dietary industrial trans fatty acids in Kenya: cost-effectiveness analysis
por: Marklund, Matti, et al.
Publicado: (2023)

The indirect costs of ischemic heart disease through lost productive life years for Australia from 2015 to 2030: results from a microsimulation model
por: Schofield, Deborah, et al.
Publicado: (2019)

Assessing Cost-Effectiveness in Obesity (ACE-Obesity): an overview of the ACE approach, economic methods and cost results
por: Carter, Rob, et al.
Publicado: (2009)

Cost-Effectiveness of Total Hip and Knee Replacements for the Australian Population with Osteoarthritis: Discrete-Event Simulation Model
por: Higashi, Hideki, et al.
Publicado: (2011)

Indirect costs of depression and other mental and behavioural disorders for Australia from 2015 to 2030
por: Schofield, Deborah, et al.
Publicado: (2019)

Cost-effectiveness of psychotherapies and pharmacotherapies for mental disorders
por: McCrone, P.
Publicado: (2023)

Modelling the potential impact of a sugar-sweetened beverage tax on stroke mortality, costs and health-adjusted life years in South Africa
por: Manyema, Mercy, et al.
Publicado: (2016)

Stakeholder-engaged research: strategies for the prevention and control of overweight and obesity in Kenya
por: Wanjau, Mary Njeri, et al.
Publicado: (2021)

Determinants of Obesity and Associated Population Attributability, South Africa: Empirical Evidence from a National Panel Survey, 2008-2012
por: Sartorius, Benn, et al.
Publicado: (2015)

On the Futility of Screening for Genes That Make You Fat
por: Veerman, J. Lennert
Publicado: (2011)

Obesity pharmacotherapy: current status
por: Kumar, Parveen, et al.
Publicado: (2015)

Obesity Treatment – Is Pharmacotherapy the Answer?
por: Rangbulla, Aditya Kumar
Publicado: (2020)

Dietary fats: a new look at old data challenges established wisdom
por: Veerman, J Lennert
Publicado: (2016)

A generic model for the assessment of disease epidemiology: the computational basis of DisMod II
por: Barendregt, Jan J, et al.
Publicado: (2003)

Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis
por: Hendrix, Nathaniel, et al.
Publicado: (2018)

Pharmacotherapies for Obesity: Past, Current, and Future Therapies
por: Ioannides-Demos, Lisa L., et al.
Publicado: (2011)

A cost–benefit analysis framework for preventive health interventions to aid decision-making in Australian governments
por: Ananthapavan, Jaithri, et al.
Publicado: (2021)

Systematic review of the cost‐effectiveness of preoperative antibiotic prophylaxis in reducing surgical‐site infection
por: Allen, J., et al.
Publicado: (2018)

GLP-1 physiology informs the pharmacotherapy of obesity
por: Drucker, Daniel J.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jdv2ebomf9nkivev31cb6okhtr